Most recent update: Friday, January 24, 2020 - 11:27

Bariatric News - Cookies & privacy policy

You are here

five years

Two RCTs show little difference between RYGB and LSG at five years

The five-year outcomes from two randomised clinical trials both assessing sleeve gastrectomy (LSG) vs laparoscopic Roux-en-y gastric bypass (RYGB), have concluded that there is no significant difference in regard to excess BMI loss between the two procedures, although in both trials RYGB did result in greater percentage excess BMI loss.

STAMPEDE: Five-year data shows benefits of surgery

Bariatric and metabolic surgery with intensive medical therapy is a better long-term treatment option than intensive medical therapy alone, for patients with obesity (BMI≥27) and uncontrolled type 2 diabetes, according to the five-year outcomes from the STAMPEDE (Surgical Treatment And Medications Potentially Eradicate Diabetes Efficiently) study.

Subscribe to RSS - five years